Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT03652441 · COMPLETED
Trial details
- NCT number
- NCT03652441
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2023-08-10
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.